Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,120.40
(
0.44%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.65
(
2.39%
)
Bitcoin
74,274.94
(
-0.76%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 150793

Wednesday, 10/17/2012 4:33:12 PM

Wednesday, October 17, 2012 4:33:12 PM

Post# of 257253
ABT’s all-oral phase-3 trial in HCV:

They said they use ritonavir at a much lower dose so presumably less tolerability issues from this one.

http://seekingalpha.com/article/930191-abbott-laboratories-management-discusses-q3-2012-results-earnings-call-transcript
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now